Tetsuya Tajima, Koichiro Hata, Hironori Haga, Momoko Nishikori, Katsutsugu Umeda, Jiro Kusakabe, Hidetaka Miyauchi, Tatsuya Okamoto, Eri Ogawa, Mari Sonoda, Hidefumi Hiramatsu, Masakazu Fujimoto, Hideaki Okajima, Junko Takita, Akifumi Takaori‐Kondo, Shinji Uemoto – 1 March 2021 – Post‐transplant lymphoproliferative disorders (PTLDs) are life‐threatening neoplasms after organ transplantation. Because of their rarity and multiple grades of malignancy, the incidence, outcomes, and clinicopathological features affecting patient survival after liver transplantation (LT) remain unclear.